• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Aeolus Pharmaceuticals Inc

+ Add to Watchlist


Price not available for IC9A:GR

Snapshot for Aeolus Pharmaceuticals Inc (IC9A)

Open: - Day's Range: - Volume: 0
Previous Close: 0.190 52wk Range: - 1-Yr Rtn: -

Stock Chart for IC9A

No chart data available.
  • IC9A:GR
  • 1M
  • 1Y
Interactive IC9A Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IC9A

Current P/E Ratio (ttm) -
Estimated P/E(09/2015) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (09/2015) -0.0200
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 135.85
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IC9A

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for IC9A

Aeolus Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops catalytic antioxidants for use in oncology, and in treating central nervous system, respiratory, and autoimmune disorders.

David C CavalierCFO/Chairman/SecryJohn L McManusPresident/CEO
More Company Profile & Key Executives for IC9A

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil